INGENUITY Trademark

Trademark Overview


On Tuesday, March 5, 2024, a trademark application was filed for INGENUITY with the United States Patent and Trademark Office. The USPTO has given the INGENUITY trademark a serial number of 98434174. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, March 5, 2024. This trademark is owned by ALVEOGENE LIMITED. The INGENUITY trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Therapeutics and prophylactic preparations for medical and veterinary purposes in the field of gene therapy; vectors and lentiviral vectors for therapeutic and prophylactic purposes; vectors and lentiviral vectors for use in gene therapy; therapeutic and prophylactic preparations for gene therapy; therapeutic preparations for treating respiratory disorders and diseases; prophylactic preparations for preventing respiratory disorders and diseases; platform technologies being drug delivery agents for treating respiratory disorders and diseases

Chemicals, proteins and vectors for scientific and research use; lentiviral vectors for scientific and research use; chemicals for use in the manufacture of vectors and lentiviral vectors; chemicals for use in gene therapy research
ingenuity

General Information


Serial Number98434174
Word MarkINGENUITY
Filing DateTuesday, March 5, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, March 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesTherapeutics and prophylactic preparations for medical and veterinary purposes in the field of gene therapy; vectors and lentiviral vectors for therapeutic and prophylactic purposes; vectors and lentiviral vectors for use in gene therapy; therapeutic and prophylactic preparations for gene therapy; therapeutic preparations for treating respiratory disorders and diseases; prophylactic preparations for preventing respiratory disorders and diseases; platform technologies being drug delivery agents for treating respiratory disorders and diseases
Goods and ServicesChemicals, proteins and vectors for scientific and research use; lentiviral vectors for scientific and research use; chemicals for use in the manufacture of vectors and lentiviral vectors; chemicals for use in gene therapy research

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, March 5, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 5, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameALVEOGENE LIMITED
Party Type10 - Original Applicant
Legal Entity Type24 - NOT AVAILABLE
AddressOxford OX26HT
GB

Trademark Events


Event DateEvent Description
Tuesday, March 5, 2024NEW APPLICATION ENTERED
Tuesday, March 5, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 20, 2024PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, August 20, 2024ASSIGNED TO LIE
Wednesday, March 6, 2024TEAS VOLUNTARY AMENDMENT RECEIVED